CFG
ABBV icon

Capstone Financial Group’s AbbVie ABBV Stock Holding History

Capstone Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$274K Buy
3,189
+2,938
+1,171% +$277K 0.21% 70
2020
Q2 		$25K Buy
+251
New +$22.1K 0.02% 141
2020
Q1 		– Sell
-251
Closed -$22K – 139
2019
Q4 		$22K Buy
+251
New +$20.8K 0.02% 147

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Capstone Financial Group's ABBV Position: Q3 2020 in Review

Capstone Financial Group increased its AbbVie (ABBV) stake by 1,171% in Q3 2020, buying an estimated $277K and bringing the position to 3,189 shares worth $274K. The position accounts for 0.21% of the portfolio, ranked #70.

Capstone Financial Group first reported a position in ABBV in Q4 2019 and has held it in 3 quarters since. 2,366 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

  • Capstone Financial Group held 3,189 shares of AbbVie worth $274K as of Q3 2020.
  • Capstone Financial Group bought 2,938 AbbVie shares in Q3 2020, an estimated $277K.
  • AbbVie made up 0.21% of Capstone Financial Group's portfolio in Q3 2020, its #70 holding.
  • Capstone Financial Group first reported a position in AbbVie in Q4 2019 and has held it in 3 quarters since.
  • 2,366 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Capstone Financial Group's 13F filing for Q3 2020, filed 9 Oct 2020.